AUGVESTA Trademark

Trademark Overview

On Wednesday, February 9, 2022, a trademark application was filed for AUGVESTA with the United States Patent and Trademark Office. The USPTO has given the AUGVESTA trademark a serial number of 97260157. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 8, 2023. This trademark is owned by Pfizer Inc.. The AUGVESTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy
augvesta

General Information

Serial Number97260157
Word MarkAUGVESTA
Filing DateWednesday, February 9, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 8, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of muscular dystrophy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, May 8, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 8, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, May 8, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 24, 2022NON-FINAL ACTION E-MAILED
Monday, October 24, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 12, 2022NEW APPLICATION ENTERED

Related Keywords

augvesta preparations pharmaceutical disorders treatment stroke pain obesity hypertension skin growth